Cargando…

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review

Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, because of excessive inflammation, platelet activation, endothelia...

Descripción completa

Detalles Bibliográficos
Autores principales: Bikdeli, Behnood, Madhavan, Mahesh V., Jimenez, David, Chuich, Taylor, Dreyfus, Isaac, Driggin, Elissa, Nigoghossian, Caroline Der, Ageno, Walter, Madjid, Mohammad, Guo, Yutao, Tang, Liang V., Hu, Yu, Giri, Jay, Cushman, Mary, Quéré, Isabelle, Dimakakos, Evangelos P., Gibson, C. Michael, Lippi, Giuseppe, Favaloro, Emmanuel J., Fareed, Jawed, Caprini, Joseph A., Tafur, Alfonso J., Burton, John R., Francese, Dominic P., Wang, Elizabeth Y., Falanga, Anna, McLintock, Claire, Hunt, Beverley J., Spyropoulos, Alex C., Barnes, Geoffrey D., Eikelboom, John W., Weinberg, Ido, Schulman, Sam, Carrier, Marc, Piazza, Gregory, Beckman, Joshua A., Steg, P. Gabriel, Stone, Gregg W., Rosenkranz, Stephan, Goldhaber, Samuel Z., Parikh, Sahil A., Monreal, Manuel, Krumholz, Harlan M., Konstantinides, Stavros V., Weitz, Jeffrey I., Lip, Gregory Y.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American College of Cardiology Foundation. Published by Elsevier. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164881/
https://www.ncbi.nlm.nih.gov/pubmed/32311448
http://dx.doi.org/10.1016/j.jacc.2020.04.031